This is a Validated Antibody Database (VAD) review about dog CD44, based on 234 published articles (read how Labome selects the articles), using CD44 antibody in all methods. It is aimed to help Labome visitors find the most suited CD44 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD44 synonym: CD44 antigen; CD44 molecule (Indian blood group); ECMR-III; GP90 lymphocyte homing/adhesion receptor; HUTCH-I; PGP-1; PGP-I; extracellular matrix receptor-III; hermes antigen; hyaluronate receptor; phagocytic glycoprotein 1; phagocytic glycoprotein I

BioLegend
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend CD44 antibody (Biolegend, 103057) was used in flow cytometry on mouse samples (fig 2h). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1d
BioLegend CD44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples at 1:200 (fig 1d). elife (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8b
BioLegend CD44 antibody (BioLegend, 103054) was used in flow cytometry on mouse samples (fig s8b). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend CD44 antibody (Biolegend, 103039) was used in flow cytometry on mouse samples (fig 5c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8c). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1f). J Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend CD44 antibody (Biolegend, 103043) was used in flow cytometry on mouse samples (fig 1e). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD44 antibody (Biolegend, 103047) was used in flow cytometry on mouse samples (fig 2b). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s5d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5d). JCI Insight (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 1c
BioLegend CD44 antibody (Biolegend, 103012) was used in flow cytometry on mouse samples at 1:400 (fig 1c). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend CD44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples (fig 7a). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 5d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 5d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). PLoS ONE (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1c). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s19
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s19). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e2e
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig e2e). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3f). EMBO J (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2h). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (BioLegend, 103020) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
  • immunocytochemistry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (Biolegend, 103035) was used in flow cytometry on mouse samples (fig 1b) and in immunocytochemistry on mouse samples (fig 1c). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1h
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1h). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; scFv; loading ...; fig 1c
  • immunoprecipitation; human; loading ...; fig sf1
  • immunocytochemistry; human; 1:250; loading ...; fig sf2
BioLegend CD44 antibody (Biolegend, IM-7) was used in flow cytometry on scFv samples (fig 1c), in immunoprecipitation on human samples (fig sf1) and in immunocytochemistry on human samples at 1:250 (fig sf2). Oncotarget (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4c). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s1a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig s1a). Nat Commun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
In order to evaluate mouse models of hepacivirus infection, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s8c). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2k
In order to investigate the role of dopamine in B cell maturation in germinal centres, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2k). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
In order to characterize the regulatory T cells expressing T-bet transcriptional factor, BioLegend CD44 antibody (BioLegend, 103026) was used in flow cytometry on mouse samples (fig 3f). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s3b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s3b). Nat Commun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1c
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3a). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4f). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on human samples (fig 2b). Oncogenesis (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to find factors that regulate follicular T helper cell migration and function, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5b). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3c). Nat Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend CD44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to assess the contribution of viral infection to the development of celiac disease, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 1f
  • flow cytometry; cat; loading ...; fig 1e
In order to compare human and feline adipose-derived mesenchymal stem cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on human samples (fig 1f) and in flow cytometry on cat samples (fig 1e). Stem Cell Res Ther (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6b). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to examine the contribution of T-bet-expressing B cells to autoimmune diseases, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 2b). Stem Cells Dev (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Mucosal Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Oncotarget (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to report that differentiation and self-renewal arise as opposing outcomes of sibling CD4 positive T cells during challenge with influenza, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to investigate strains of Listeria monocytogenes that activate necrosis, apoptosis, or pyroptosis and study the role of CD8 positive T cells in these processes, BioLegend CD44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Infect Immun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 6c
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 6c). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6f
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4
In order to characterize systemic antimicrobial CD4 positive T cell reactivity, BioLegend CD44 antibody (Biolegend, Im7) was used in flow cytometry on mouse samples (fig s4). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; loading ...; fig 5e
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:800 (fig 5e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (BioLegend, 103022) was used . Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3
BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; loading ...; fig 3g
BioLegend CD44 antibody (BioLegend, IM7) was used in immunocytochemistry on human samples (fig 3g). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6d
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig s1). Cell (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2
BioLegend CD44 antibody (Biolegend, 103015) was used in flow cytometry on human samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig S1
In order to study the effect of IL-10 signaling in infectious neurological diseases, BioLegend CD44 antibody (BioLegend, clone IM7) was used in flow cytometry on mouse samples (fig S1). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to probe how neutrophil extracellular traps modulate the rheumatoid arthritis-associated autoimmune response, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Eur J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3d
In order to test if a combination of LYN and Aire defects result in organ-specific autoimmunity, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to demonstrate that lymphotoxin beta receptor directly controls thymic endothelial cells to guide hematopoietic progenitor cell homing, BioLegend CD44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to assess how ABCG1 loss in T cells affects atherosclerosis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 4
BioLegend CD44 antibody (Biolegend, 103015) was used in immunocytochemistry on human samples (fig 4). Biol Open (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 4
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 4). J Virol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 4
BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples at 1:100 (fig 4). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 4f
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 4f). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; loading ...; fig 1a
  • immunohistochemistry; human; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, IM7) was used in immunohistochemistry on mouse samples (fig 1a) and in immunohistochemistry on human samples (fig 1a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
In order to study promotion of host immunity and protection against IL-12/23p40-dependent lung injury during hookworm infection by myeloid-restricted AMPK-alpha1, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3e
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3c
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Gastroenterology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1b
BioLegend CD44 antibody (Biolegend, 103029) was used in flow cytometry on human samples (fig 1b). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6s
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6s). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend CD44 antibody (Biolegend, 1M7) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2f
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, BioLegend CD44 antibody (BioLegend, 103016) was used in flow cytometry on mouse samples at 1:400 (fig 2f). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Int J Oncol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend CD44 antibody (Biolegend, 103026) was used in flow cytometry on mouse samples (fig 6). Nature (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, 103030) was used . Sci Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; cat; fig 2
In order to examine the effect of fresh, autologous, adipose-derived mesenchymal stem cells on feline chronic gingivostomatitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on cat samples (fig 2). Stem Cells Transl Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend CD44 antibody (BioLegend, IMF7) was used in flow cytometry on mouse samples (fig 1). Nat Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1d). Arthritis Rheumatol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s7
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s7). elife (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (BioLegend, 103021) was used . Mol Med Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3a). Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Leukoc Biol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, IM7) was used . Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s6
BioLegend CD44 antibody (Biolegend, 103024) was used in flow cytometry on mouse samples (fig s6). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 1
BioLegend CD44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s2). Brain (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
BioLegend CD44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 3). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, 103012) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to examine the role of interleukin-4 in relation to eomesodermin within CD8+ T cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; human; fig 2
  • flow cytometry; mouse; fig 1
In order to study reprogramming of cells toward a metastatic-like state by p53 psi, a transcriptionally inactive p53 isoform, BioLegend CD44 antibody (Biolegend, IM-7) was used in immunohistochemistry on human samples (fig 2) and in flow cytometry on mouse samples (fig 1). Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate how Fbw7-mediated GATA3 regulation and CDK2-mediated phosphorylation of Cdc4 phosphodegron regulate differentiation of T-cell lineages, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Mol Cell Biol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples . Ann Neurol (2014) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, 103014) was used . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
BioLegend CD44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 4). Vaccine (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:200; loading ...; fig st13
BioLegend CD44 antibody (Biolengend, IM7) was used in immunocytochemistry on human samples at 1:200 (fig st13). Nat Cell Biol (2014) ncbi
rat monoclonal (IM7)
In order to evaluate a coculture system for in vitro colonoid formation, BioLegend CD44 antibody (Biolegend, 103001) was used . Am J Physiol Gastrointest Liver Physiol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend CD44 antibody (BioLegend, 103009) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cell Cycle (2012) ncbi
Invitrogen
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a, 8b
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a, 8b). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 6d
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 6d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig ex7g
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig ex7g). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD44 antibody (Thermo Fisher Scientific, IM-7) was used in flow cytometry on mouse samples (fig 2b). Eur J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 1d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s6a). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Cell Death Dis (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e4e
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig e4e). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2j
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2j). Science (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7e). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
Invitrogen CD44 antibody (Affymetrix/eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 3a). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3g
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3g). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to investigate the role of protease-activated receptor 2 in lymphocyte development, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5b). Int J Biochem Cell Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4a). Eur J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 8a
In order to determine the role of RelB in classical dendritic cell and myeloid development, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 8a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen CD44 antibody (eBioscience, IM7) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3e
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, Invitrogen CD44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on human samples (fig 3e). Mol Cancer (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 2c). Cell Mol Life Sci (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to show that ABCA7 regulates natural killer T cell development in a cell-extrinsic manner, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Sci Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1C
In order to evaluate the potential role of the attachment of myristic acid to the N-terminal glycine of proteins on the activation of gamma delta T cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1C). J Leukoc Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to examine natural killer T cell development in mice deficient for SLAM family receptors, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to determine that NKG2C/E identifies the CD4 T cell effector subset ThCTL that develop in the lung during influenza A virus infection in mice, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
  • immunocytochemistry; mouse; fig 2h
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a) and in immunocytochemistry on mouse samples (fig 2h). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s4a
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s4a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to discuss differences in eosinophil degranulation between humans and mice, Invitrogen CD44 antibody (eBiosciences, M27) was used in flow cytometry on mouse samples (fig s1). Am J Respir Crit Care Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to find a role for RAB43 in cross-presentation by classical dendritic cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Cell Death Dis (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3e
In order to characterize side population T cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 3e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2c). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; pig; fig 1b
  • immunocytochemistry; pig; 1:100; fig 1a
In order to assess the presence of vitamin D machinery on porcine adipose-derived MSCs, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on pig samples (fig 1b) and in immunocytochemistry on pig samples at 1:100 (fig 1a). Stem Cell Res Ther (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
In order to implement lck-cre transgenic mice to study the role of loxP-targeted genes in T cell development and function, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6f
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen CD44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6f). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Am J Pathol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:500; loading ...; fig s10
In order to elucidate cellular mechanisms that regulate the formation of clusters of circulating tumor cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in immunocytochemistry on human samples at 1:500 (fig s10). J R Soc Interface (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig cd44
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig cd44). Diabetes (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 7). elife (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to report that the majority of microbe-specific naive T cells produced memory cells during infection, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of miR-34a in efferocytosis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2a
In order to find that breast cancer stem cells isolated with CD44(+)CD24(-/lo)SSEA-3(+) or ESA(hi)PROCR(hi)SSEA-3(+) markers have higher tumorigenicity than those with conventional markers, Invitrogen CD44 antibody (eBioscience, IM-7) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to study the polysialylation of CCR7, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Nat Genet (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 0.2 ug/ml; fig 2
In order to investigate how CD44 modulation induced resistance to type 1 diabetes in NOD mice, Invitrogen CD44 antibody (Thermo Scientific, MA1-10225) was used in immunohistochemistry on mouse samples at 0.2 ug/ml (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2e
  • flow cytometry; human; 1:100; fig 2g
  • immunocytochemistry; human; 1:100; fig 3e
In order to study the differentiation of oral mucosa stromal cells into neural crest stem cells and assess their therapeutic value, Invitrogen CD44 antibody (eBioscience, IM7) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2e), in flow cytometry on human samples at 1:100 (fig 2g) and in immunocytochemistry on human samples at 1:100 (fig 3e). Stem Cells Transl Med (2016) ncbi
rat monoclonal (YKIX337.8)
  • flow cytometry; dog; 1:2000; fig 5
  • immunocytochemistry; dog; 1:500; fig 7
In order to determine the effects of cryopreservation on canine adipose-derived multipotent stromal cells, Invitrogen CD44 antibody (eBiosciences, 115440) was used in flow cytometry on dog samples at 1:2000 (fig 5) and in immunocytochemistry on dog samples at 1:500 (fig 7). Stem Cell Rev (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7b
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7b). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
In order to investigate the role of Rpl22 during early B cell development, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the immunogenicity and immunomodulatory properties of bone marrow-derived mesenchymal stem cells using an allogeneic mouse model, Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples . J Tissue Eng (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to evaluate the use of biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles as a vaccine delivery system, Invitrogen CD44 antibody (E-Bioscience, 1M7) was used in flow cytometry on mouse samples . J Biomed Mater Res A (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report two Treg subsets with distinct phenotypes and homeostasis in normal unmanipulated mice, Invitrogen CD44 antibody (Zymed, IM7) was used in flow cytometry on mouse samples . J Exp Med (2003) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to characterize murine tumor-infiltrating lymphocytes, Invitrogen CD44 antibody (CalTag, IM7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to study CD44 and hyaluronic acid interactions, Invitrogen CD44 antibody (noco, IM7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (1992) ncbi
Santa Cruz Biotechnology
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-18849) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
Santa Cruz Biotechnology CD44 antibody (santa Cruz, sc-18849) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Int J Mol Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3a
Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-18849) was used in flow cytometry on human samples (fig 3a). Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; 1:50
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotech, sc-18849) was used in immunocytochemistry on mouse samples at 1:50. Reproduction (2010) ncbi
R&D Systems
mouse monoclonal (69-S5)
  • flow cytometry; horses; loading ...; fig 1
R&D Systems CD44 antibody (R&D Systems, MAB5449) was used in flow cytometry on horses samples (fig 1). Oxid Med Cell Longev (2016) ncbi
mouse monoclonal (69-S5)
  • flow cytometry; dog; fig s1c
R&D Systems CD44 antibody (R&D Systems, FAB5449A) was used in flow cytometry on dog samples (fig s1c). Nucleic Acids Res (2016) ncbi
Bio-Rad
rat monoclonal (YKIX337.8.7)
  • flow cytometry; dog
Bio-Rad CD44 antibody (Serotec, MCA1041A488) was used in flow cytometry on dog samples . Acta Vet Scand (2014) ncbi
MilliporeSigma
mouse monoclonal (MEM-263)
  • flow cytometry; human; fig 3
MilliporeSigma CD44 antibody (Sigma, SAB4700184) was used in flow cytometry on human samples (fig 3). BMC Res Notes (2015) ncbi
Articles Reviewed
  1. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  2. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  3. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun. 2019;10:1492 pubmed publisher
  4. Sinclair L, Howden A, Brenes A, Spinelli L, Hukelmann J, Macintyre A, et al. Antigen receptor control of methionine metabolism in T cells. elife. 2019;8: pubmed publisher
  5. Michaels Y, Barnkob M, Barbosa H, Baeumler T, Thompson M, Andre V, et al. Precise tuning of gene expression levels in mammalian cells. Nat Commun. 2019;10:818 pubmed publisher
  6. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  7. Yamamoto T, Lee P, Vodnala S, Gurusamy D, Kishton R, Yu Z, et al. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019;129:1551-1565 pubmed publisher
  8. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  9. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed publisher
  10. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed publisher
  11. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  12. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  13. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  14. Gejman R, Chang A, Jones H, DiKun K, Hakimi A, Schietinger A, et al. Rejection of immunogenic tumor clones is limited by clonal fraction. elife. 2018;7: pubmed publisher
  15. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed publisher
  16. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  17. Glal D, Sudhakar J, Lu H, Liu M, Chiang H, Liu Y, et al. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol. 2018;9:2522 pubmed publisher
  18. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  19. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  20. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  21. Sang A, Danhorn T, Peterson J, Rankin A, O Connor B, Leach S, et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun. 2018;9:3973 pubmed publisher
  22. Cummings M, Arumanayagam A, Zhao P, Kannanganat S, Stuve O, Karandikar N, et al. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE. 2018;13:e0200752 pubmed publisher
  23. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  24. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  25. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  26. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  27. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed publisher
  28. Nusse Y, Savage A, Marangoni P, Rosendahl Huber A, Landman T, De Sauvage F, et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature. 2018;559:109-113 pubmed publisher
  29. Feng Y, Liao Y, Huang W, Lai X, Luo J, Du C, et al. Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis. Cell Death Dis. 2018;9:691 pubmed publisher
  30. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  31. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360: pubmed publisher
  32. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  33. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  34. Drobek A, Moudra A, Mueller D, Huranová M, Horková V, Pribikova M, et al. Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells. EMBO J. 2018;37: pubmed publisher
  35. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  36. Gounder A, Yokoyama C, Jarjour N, Bricker T, Edelson B, Boon A. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 2018;14:e1007001 pubmed publisher
  37. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  38. Zhang Y, Tech L, George L, Acs A, Durrett R, Hess H, et al. Plasma cell output from germinal centers is regulated by signals from Tfh and stromal cells. J Exp Med. 2018;215:1227-1243 pubmed publisher
  39. Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9:1095 pubmed publisher
  40. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  41. Khan A, Carpenter B, Santos e Sousa P, Pospori C, Khorshed R, Griffin J, et al. Redirection to the bone marrow improves T cell persistence and antitumor functions. J Clin Invest. 2018;128:2010-2024 pubmed publisher
  42. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  43. Kotov D, Kotov J, Goldberg M, Jenkins M. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. J Immunol. 2018;200:2004-2012 pubmed publisher
  44. Fahl S, Coffey F, Kain L, Zarin P, Dunbrack R, Teyton L, et al. Role of a selecting ligand in shaping the murine γδ-TCR repertoire. Proc Natl Acad Sci U S A. 2018;115:1889-1894 pubmed publisher
  45. Chen X, Nagai Y, Zhu Z, Ruan H, Peehl D, Greene M, et al. A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77. Oncotarget. 2018;9:3631-3640 pubmed publisher
  46. Ellestad K, Thangavelu G, Haile Y, Lin J, Boon L, Anderson C. Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1. Front Immunol. 2018;9:12 pubmed publisher
  47. Koh A, Miller E, Buenrostro J, Moskowitz D, Wang J, Greenleaf W, et al. Rapid chromatin repression by Aire provides precise control of immune tolerance. Nat Immunol. 2018;19:162-172 pubmed publisher
  48. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  49. Nakashima H, Alayo Q, Penaloza MacMaster P, Freeman G, Kuchroo V, Reardon D, et al. Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells. Sci Rep. 2018;8:208 pubmed publisher
  50. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  51. Ernszt D, Banfai K, Kellermayer Z, Pap A, Lord J, Pongracz J, et al. PPARgamma Deficiency Counteracts Thymic Senescence. Front Immunol. 2017;8:1515 pubmed publisher
  52. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  53. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  54. Francis N, Every A, Ayodele B, Pike R, Mackie E, Pagel C. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development. Int J Biochem Cell Biol. 2017;92:95-103 pubmed publisher
  55. Blanchfield L, Sabatino J, Lawrence L, Evavold B. NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease. J Immunol. 2017;199:2680-2691 pubmed publisher
  56. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  57. Li L, Labuda J, Imai D, Griffey S, McSorley S. CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract. J Immunol. 2017;199:2547-2554 pubmed publisher
  58. Wang Y, Yun C, Gao B, Xu Y, Zhang Y, Wang Y, et al. The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation. Cell Rep. 2017;20:600-612 pubmed publisher
  59. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  60. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  61. Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421-425 pubmed publisher
  62. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  63. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  64. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  65. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  66. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  67. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  68. Lu P, Shih C, Qi H. Ephrin B1-mediated repulsion and signaling control germinal center T cell territoriality and function. Science. 2017;356: pubmed publisher
  69. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  70. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  71. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  72. Lino C, Barros Martins J, Oberdörfer L, Walzer T, Prinz I. Eomes expression reports the progressive differentiation of IFN-?-producing Th1-like ?? T cells. Eur J Immunol. 2017;47:970-981 pubmed publisher
  73. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  74. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  75. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  76. Briseño C, Gargaro M, Durai V, Davidson J, Theisen D, Anderson D, et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A. 2017;114:3957-3962 pubmed publisher
  77. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  78. Clark K, Fierro F, Ko E, Walker N, Arzi B, Tepper C, et al. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther. 2017;8:69 pubmed publisher
  79. Bhattacharyya M, Penaloza MacMaster P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology. 2017;151:340-348 pubmed publisher
  80. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  81. Rubtsova K, Rubtsov A, Thurman J, Mennona J, Kappler J, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 2017;127:1392-1404 pubmed publisher
  82. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  83. Horvatinovich J, Grogan E, Norris M, Steinkasserer A, Lemos H, Mellor A, et al. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes. J Immunol. 2017;198:2286-2301 pubmed publisher
  84. Duhachek Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, et al. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer. 2017;16:32 pubmed publisher
  85. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  86. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed publisher
  87. Nowyhed H, Chandra S, Kiosses W, Marcovecchio P, Andary F, Zhao M, et al. ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep. 2017;7:40273 pubmed publisher
  88. Rampoldi F, Brunk F, Bonrouhi M, Federico G, Krunic D, Porubsky S, et al. Deficiency of N-myristoylation reveals calcineurin activity as regulator of IFN-?-producing ?? T cells. J Leukoc Biol. 2017;101:1005-1014 pubmed publisher
  89. Marycz K, Kornicka K, Grzesiak J, Smieszek A, Szłapka J. Macroautophagy and Selective Mitophagy Ameliorate Chondrogenic Differentiation Potential in Adipose Stem Cells of Equine Metabolic Syndrome: New Findings in the Field of Progenitor Cells Differentiation. Oxid Med Cell Longev. 2016;2016:3718468 pubmed publisher
  90. Chen S, Cai C, Li Z, Liu G, Wang Y, Blonska M, et al. Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. J Exp Med. 2017;214:475-489 pubmed publisher
  91. Marshall N, Vong A, Devarajan P, Brauner M, Kuang Y, Nayar R, et al. NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol. 2017;198:1142-1155 pubmed publisher
  92. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  93. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  94. Griffiths K, Ahmed M, Das S, Gopal R, Horne W, Connell T, et al. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016;7:13894 pubmed publisher
  95. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  96. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed publisher
  97. Nish S, Zens K, Kratchmarov R, Lin W, Adams W, Chen Y, et al. CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med. 2017;214:39-47 pubmed publisher
  98. Jacobsen E, Ochkur S, Doyle A, Lesuer W, Li W, Protheroe C, et al. Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation. Am J Respir Crit Care Med. 2017;195:1321-1332 pubmed publisher
  99. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  100. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  101. Kretzer N, Theisen D, Tussiwand R, Briseño C, Grajales Reyes G, Wu X, et al. RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med. 2016;213:2871-2883 pubmed
  102. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  103. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed publisher
  104. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  105. Theisen E, Sauer J. Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. Infect Immun. 2017;85: pubmed publisher
  106. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  107. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  108. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  109. Kwong Chung C, Ronchi F, Geuking M. Detrimental effect of systemic antimicrobial CD4+ T-cell reactivity on gut epithelial integrity. Immunology. 2017;150:221-235 pubmed publisher
  110. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  111. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  112. Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
  113. Liu Z, Tian R, Li Y, Zhang L, Shao H, Yang C, et al. SDF-1?-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia. Sci Rep. 2016;6:34416 pubmed publisher
  114. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  115. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  116. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  117. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  118. Chai Y, Lee E, Gubbe J, Brekke J. 3D Cell Culture in a Self-Assembled Nanofiber Environment. PLoS ONE. 2016;11:e0162853 pubmed publisher
  119. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  120. Uhde A, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, et al. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS ONE. 2016;11:e0161883 pubmed publisher
  121. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  122. Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46:2542-2554 pubmed publisher
  123. Proekt I, Miller C, Jeanne M, Fasano K, Moon J, Lowell C, et al. LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity. J Clin Invest. 2016;126:3758-3771 pubmed publisher
  124. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  125. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  126. Valle Y, Almalki S, Agrawal D. Vitamin D machinery and metabolism in porcine adipose-derived mesenchymal stem cells. Stem Cell Res Ther. 2016;7:118 pubmed publisher
  127. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  128. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed publisher
  129. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  130. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed publisher
  131. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  132. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  133. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  134. Liu W, Kang S, Huang Z, Wu C, Jin H, Maine C, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901-19 pubmed publisher
  135. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  136. Stanly T, Fritzsche M, Banerji S, Garcia E, Bernardino de la Serna J, Jackson D, et al. Critical importance of appropriate fixation conditions for faithful imaging of receptor microclusters. Biol Open. 2016;5:1343-50 pubmed publisher
  137. Di Scala M, Otano I, Gil Farina I, Vanrell L, Hommel M, Olague C, et al. Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice. J Virol. 2016;90:8563-74 pubmed publisher
  138. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  139. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  140. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  141. Nasri I, Bonnet D, Zwarycz B, d Aldebert E, Khou S, Mezghani Jarraya R, et al. PAR2-dependent activation of GSK3? regulates the survival of colon stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol. 2016;311:G221-36 pubmed publisher
  142. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  143. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  144. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  145. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  146. Nieves W, Hung L, Oniskey T, Boon L, Foretz M, Viollet B, et al. Myeloid-Restricted AMPK?1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection. J Immunol. 2016;196:4632-40 pubmed publisher
  147. Boareto M, Jolly M, Goldman A, Pietila M, Mani S, Sengupta S, et al. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface. 2016;13: pubmed publisher
  148. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  149. Rialdi A, Campisi L, Zhao N, Lagda A, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352:aad7993 pubmed publisher
  150. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  151. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  152. Mall C, Sckisel G, Proia D, Mirsoian A, Grossenbacher S, Pai C, et al. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016;5:e1075114 pubmed
  153. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  154. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  155. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  156. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  157. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  158. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  159. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  160. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  161. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  162. Pelly V, Kannan Y, Coomes S, Entwistle L, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407-1417 pubmed publisher
  163. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  164. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  165. Tubo N, Fife B, Pagán A, Kotov D, Goldberg M, Jenkins M. Most microbe-specific naïve CD4? T cells produce memory cells during infection. Science. 2016;351:511-4 pubmed publisher
  166. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  167. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  168. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  169. McCubbrey A, Nelson J, Stolberg V, Blakely P, McCloskey L, Janssen W, et al. MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol. 2016;196:1366-75 pubmed publisher
  170. Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, et al. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol. 2016;48:953-64 pubmed publisher
  171. Loperfido M, Jarmin S, Dastidar S, Di Matteo M, Perini I, Moore M, et al. piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts. Nucleic Acids Res. 2016;44:744-60 pubmed publisher
  172. Cheung S, Chuang P, Huang H, Hwang Verslues W, Cho C, Yang W, et al. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proc Natl Acad Sci U S A. 2016;113:960-5 pubmed publisher
  173. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  174. Schosserer M, Reynoso R, Wally V, Jug B, Kantner V, Weilner S, et al. Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa. BMC Res Notes. 2015;8:767 pubmed publisher
  175. Lindemans C, Calafiore M, Mertelsmann A, O Connor M, Dudakov J, Jenq R, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528:560-564 pubmed publisher
  176. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  177. Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George G, Hong D, et al. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015;5:17533 pubmed publisher
  178. Assayag Asherie N, Sever D, Bogdani M, Johnson P, Weiss T, Ginzberg A, et al. Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes. PLoS ONE. 2015;10:e0143589 pubmed publisher
  179. Abe S, Yamaguchi S, Sato Y, Harada K. Sphere-Derived Multipotent Progenitor Cells Obtained From Human Oral Mucosa Are Enriched in Neural Crest Cells. Stem Cells Transl Med. 2016;5:117-28 pubmed publisher
  180. Arzi B, Mills Ko E, Verstraete F, Kol A, Walker N, Badgley M, et al. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Transl Med. 2016;5:75-86 pubmed publisher
  181. Duan W, Lopez M. Effects of Cryopreservation on Canine Multipotent Stromal Cells from Subcutaneous and Infrapatellar Adipose Tissue. Stem Cell Rev. 2016;12:257-68 pubmed publisher
  182. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  183. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  184. Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias G, et al. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016;68:449-61 pubmed publisher
  185. McCormack R, de Armas L, Shiratsuchi M, Fiorentino D, Olsson M, Lichtenheld M, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. elife. 2015;4: pubmed publisher
  186. Wei T, Zhang N, Guo Z, Chi F, Song Y, Zhu X. Wnt4 signaling is associated with the decrease of proliferation and increase of apoptosis during age-related thymic involution. Mol Med Rep. 2015;12:7568-76 pubmed publisher
  187. Martin Blondel G, Pignolet B, Tietz S, Yshii L, Gebauer C, Périnat T, et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur J Immunol. 2015;45:3302-12 pubmed publisher
  188. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  189. Liang Y, Hu J, Li J, Liu Y, Yu J, Zhuang X, et al. Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer. Cancer Res. 2015;75:3672-80 pubmed publisher
  190. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  191. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  192. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  193. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  194. Pei B, Zhao M, Miller B, Véla J, Bruinsma M, Virgin H, et al. Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation. J Immunol. 2015;194:5872-84 pubmed publisher
  195. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  196. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  197. Lujan E, Zunder E, Ng Y, Goronzy I, Nolan G, Wernig M. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature. 2015;521:352-6 pubmed publisher
  198. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  199. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  200. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  201. Srivastava M, Duan G, Kershaw N, Athanasopoulos V, Yeo J, Ose T, et al. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis. Nat Commun. 2015;6:6253 pubmed publisher
  202. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  203. Cabrera Perez J, Condotta S, James B, Kashem S, Brincks E, Rai D, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194:1609-20 pubmed publisher
  204. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  205. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  206. Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398-413 pubmed publisher
  207. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  208. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed publisher
  209. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  210. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  211. Ghotra V, He S, van der Horst G, Nijhoff S, de Bont H, Lekkerkerker A, et al. SYK is a candidate kinase target for the treatment of advanced prostate cancer. Cancer Res. 2015;75:230-40 pubmed publisher
  212. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed publisher
  213. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  214. Carty S, Koretzky G, Jordan M. Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS ONE. 2014;9:e106659 pubmed publisher
  215. Chatterjee S, Thyagarajan K, Kesarwani P, Song J, Soloshchenko M, Fu J, et al. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014;74:6048-59 pubmed publisher
  216. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  217. Senturk S, Yao Z, Camiolo M, Stiles B, Rathod T, Walsh A, et al. p53? is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state. Proc Natl Acad Sci U S A. 2014;111:E3287-96 pubmed publisher
  218. Kitagawa K, Shibata K, Matsumoto A, Matsumoto M, Ohhata T, Nakayama K, et al. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol. 2014;34:2732-44 pubmed
  219. Mukonoweshuro B, Brown C, Fisher J, Ingham E. Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells. J Tissue Eng. 2014;5:2041731414534255 pubmed publisher
  220. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  221. Sahlberg S, Spiegelberg D, Glimelius B, Stenerlow B, Nestor M. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS ONE. 2014;9:e94621 pubmed publisher
  222. Kang M, Park H. Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation. Acta Vet Scand. 2014;56:16 pubmed publisher
  223. Yan J, Villarreal D, Racine T, Chu J, Walters J, Morrow M, et al. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine. 2014;32:2833-42 pubmed publisher
  224. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  225. Hwang W, Jiang J, Yang S, Huang T, Lan H, Teng H, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268-80 pubmed publisher
  226. Hirokawa Y, Yip K, Tan C, Burgess A. Colonic myofibroblast cell line stimulates colonoid formation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G547-56 pubmed publisher
  227. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  228. Bonuccelli G, Castello Cros R, Capozza F, Martinez Outschoorn U, Lin Z, Tsirigos A, et al. The milk protein ?-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle. 2012;11:3972-82 pubmed publisher
  229. Yuan F, Li X, Lin J, Schwabe C, Bullesbach E, Rao C, et al. The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction. 2010;139:759-69 pubmed publisher
  230. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  231. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed
  232. Fisson S, Darrasse Jèze G, Litvinova E, Septier F, Klatzmann D, Liblau R, et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 2003;198:737-46 pubmed
  233. Radoja S, Saio M, Frey A. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166:6074-83 pubmed
  234. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade P. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992;175:257-66 pubmed